These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


301 related items for PubMed ID: 19894112

  • 1. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA, McKinley PS, Schnabel FR, El-Tamer M, Cheung YK, Fang Y, Golden CR, Frosch ME, Habif U, Mulligan MM, Chen IS, Hershman DL.
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [Abstract] [Full Text] [Related]

  • 2. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C, Savard J, Ivers H.
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [Abstract] [Full Text] [Related]

  • 3. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A, Rosen C, Hudis C, Zuckerman E, Panageas KS, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Hurria A, Holland J.
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA.
    Cancer; 2004 Jun 01; 100(11):2292-9. PubMed ID: 15160331
    [Abstract] [Full Text] [Related]

  • 6. Effect of adjuvant breast cancer chemotherapy on cognitive function from the older patient's perspective.
    Hurria A, Goldfarb S, Rosen C, Holland J, Zuckerman E, Lachs MS, Witmer M, van Gorp WG, Fornier M, D'Andrea G, Moasser M, Dang C, Van Poznak C, Robson M, Currie VE, Theodoulou M, Norton L, Hudis C.
    Breast Cancer Res Treat; 2006 Aug 01; 98(3):343-8. PubMed ID: 16541322
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study.
    Stewart A, Collins B, Mackenzie J, Tomiak E, Verma S, Bielajew C.
    Psychooncology; 2008 Feb 01; 17(2):122-30. PubMed ID: 17518411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP, Mar Fan HG, Houédé-Tchen N, Yi Q, Tannock IF.
    Psychooncology; 2006 Oct 01; 15(10):921-30. PubMed ID: 16477674
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE, Dodd MJ, Miaskowski CA, Dowling GA, Kramer J.
    Psychooncology; 2008 Dec 01; 17(12):1189-95. PubMed ID: 18506671
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study.
    Fan HG, Houédé-Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, Tannock IF.
    J Clin Oncol; 2005 Nov 01; 23(31):8025-32. PubMed ID: 16258100
    [Abstract] [Full Text] [Related]

  • 20. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, Zander AR, Koch U.
    Patient Educ Couns; 2007 Apr 01; 66(1):108-18. PubMed ID: 17320337
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.